Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-019320
Filing Date
2025-07-03
Accepted
2025-07-03 16:20:51
Documents
1
Period of Report
2025-07-01

Document Format Files

Seq Description Document Type Size
1 form4-07032025_080747.html 4  
1 form4-07032025_080747.xml 4 7523
  Complete submission text file 0001415889-25-019320.txt   9057
Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Issuer) CIK: 0001419041 (see all company filings)

EIN.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PFENEX INC. 10790 ROSELLE STREET SAN DIEGO CA 92121
Business Address
Wagner Paul A. (Reporting) CIK: 0001612842 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38052 | Film No.: 251105811